Brain Activity Patterns May Predict Alzheimer's Risk Years Early
Stanford researchers built a brain-activity score that predicts Alzheimer's risk years ahead. It compares patterns in super agers and Alzheimer's patients.
Stanford Medicine researchers report that subtle patterns of brain activity may reveal Alzheimer’s risk years before memory problems or amyloid-beta buildup appear. The same approach can flag people whose brains show unusual resistance to cognitive decline, who may go on to become “super agers.” The study was published November 4 in Science Advances.
A New Way to Spot Risk Early
The team compared adults aged 75 and older at opposite ends of cognitive aging: people with Alzheimer’s disease and super agers, whose memories resemble those of people decades younger. From the differences between the two groups, they built a scoring system and applied it to cognitively healthy adults aged 55 to 70.
People whose brain patterns looked more like those of Alzheimer’s patients were more likely to decline cognitively, develop amyloid-beta plaques, and be diagnosed with Alzheimer’s over follow-up periods of up to 12 years. People with super-ager-like patterns were more likely to stay sharp. The score predicted decline better than several established indicators, including demographics, genetic risk, and amyloid-beta and tau biomarkers.
Senior author Yu Zhang, PhD, an assistant professor of psychiatry and behavioral sciences, noted that amyloid-beta and tau show up relatively late in the disease. His goal is to find earlier markers that could allow timely intervention.
Why Super Agers Are Defined Differently Here
Depending on the definition, roughly 10% of older adults may be super agers. In this study, they were people at least 75 who scored on memory tests like a typical 45-year-old while keeping normal executive function for their age.
Earlier studies usually compared super agers with other older adults who tested normally. Zhang argued that this can hide important differences, because people with similar test scores may have very different underlying brain health. Some may already be accumulating amyloid-beta plaques, while others are not. Comparing super agers with people who have Alzheimer’s of the same age produced two more clearly defined groups.
What the Brain Scans Showed
The researchers used imaging data from the Open Access Series of Imaging Studies, the Harvard Aging Brain Study, and the Alzheimer’s Disease Neuroimaging Initiative. They analyzed resting-state functional MRI scans, which record brain activity while a person lies quietly in a scanner, from 180 super agers and 110 people with Alzheimer’s.
Some brain regions were more active and others less active in one group than in the other. These relationships are known as functional connectivity, or the functional connectome. From them the team created the Alzheimer’s resilience-vulnerability connectome score, or ARC score, which separated super agers from Alzheimer’s patients with about 85% accuracy.
Predicting Decline Before Symptoms
The team then applied the ARC score to more than 1,300 cognitively healthy adults aged 55 to 70. Lower scores indicated patterns closer to super agers, and higher scores indicated patterns closer to Alzheimer’s. At the start, cognitive performance did not differ between high and low scorers, but differences emerged over time.
Follow-up lasted as long as 12 years for some participants, though most were tracked for about five to six years. Higher, more Alzheimer’s-like scores were linked to faster declines in memory, attention, and executive function. Lower, super-ager-like scores were linked to the slowest declines.
Lead author Kanhao (Alex) Zhao, PhD, a postdoctoral scholar in psychiatry, said the score predicted conversion to mild cognitive impairment or Alzheimer’s as well as or better than existing biomarkers, and at an earlier point. Combining it with those biomarkers improved prediction further.
The team also compared ARC scores with “brain age,” an estimate of brain aging drawn from functional MRI data in healthy people. The two measures were somewhat correlated, but Zhang said ARC gives more targeted information about vulnerability or resistance to decline.
Could Brain Training Help?
The researchers stress that ARC scores are not meant to diagnose Alzheimer’s. For now, they are a possible tool for tracking cognitive health and estimating future risk. A score is also not a permanent forecast: brain activity changes over time, the share of people with super-ager-like scores falls with age, and brain injuries and neuropsychiatric conditions can affect these patterns.
Zhang hopes that change can work in a helpful direction. Future treatments might nudge brain activity toward resilient patterns, using approaches such as cognitive training or transcranial magnetic stimulation, which uses magnetic pulses to influence brain activity. The method has shown promise for changing brain activity in people treated for depression. Neither approach has been tested for preventing cognitive decline, and it is not yet known whether changing these patterns would alter the course of Alzheimer’s. His team is preparing a trial that will measure ARC scores before and after cognitive training.
Zhang emphasized that intervention must come early, which is why the work focuses on people without cognitive impairment. Researchers from Children’s National Hospital, the University of Texas at Austin, Lehigh University, Penn State College of Medicine, NYU Grossman School of Medicine, and UCLA also took part.
Whether reshaping these brain patterns can prevent or delay Alzheimer’s remains unknown. Still, by revealing risk before symptoms appear, the ARC score offers a promising new direction for finding and helping people while their cognition is still intact.